Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.

CHENNAI: The Tamil Nadu government will establish a state-of-the-art laboratory for genomic testing to strengthen cancer ...

A new review was published in Volume 12 of Oncoscience on October 13, 2025, titled "Targeted therapies and resistance ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Researchers at the University of Southampton have identified a new subtype of lymphoma which could pave the way to improved ...

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...

Delcath Systems Inc. (NASDAQ:DCTH) saw its shares rise 2.2% in premarket trading Thursday after new research underscored the potential survival benefits of its liver-targeted treatment for metastatic ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...

Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites ...

Researchers have evidence that inside shark DNA are single chain antibodies that just might help cure cancer. These flexible, ...